Skip to main content
logo
Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
84.08
+1.69 (2.06%)
At close: Apr 21, 2026, 4:00 PM EDT
83.50
-0.58 (-0.69%)
After-hours: Apr 21, 2026, 7:37 PM EDT

Inhibrx Biosciences Revenue

In the year 2025, Inhibrx Biosciences had annual revenue of $1.30M with 550.00% growth.

Revenue (ttm)
$1.30M
Revenue Growth
+550.00%
P/S Ratio
944.74
Revenue / Employee
$11,818
Employees
110
Market Cap
1.23B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.30M1.10M550.00%
Dec 31, 2024200.00K-1.60M-88.89%
Dec 31, 20231.80M-392.00K-17.88%
Dec 31, 20222.19M-5.04M-69.69%
Dec 31, 20217.23M-5.66M-43.89%
Dec 31, 202012.89M-323.00K-2.44%
Dec 31, 201913.21M4.62M53.71%
Dec 31, 20188.60M204.00K2.43%
Dec 31, 20178.39M1.72M25.86%
Dec 31, 20166.67M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Pharming Group376.13M
AbCellera Biologics75.13M
EyePoint31.37M
Zenas BioPharma10.00M
Inventiva7.94M
DBV Technologies5.64M
Maze Therapeutics2.50M
Revenue Rankings

INBX News

More News